Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
NQFClass III

Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor

21 CFR 864.1860 / Hematology

NQF is the FDA product code for Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor, a class III device type, regulated under 21 CFR 864.1860. FDA's definition for this code reads: "The epidermal growth factor receptor (EGFR) antibody/assay is a qualitative immunohistochemical antibody/assay to identify EGFR expression in normal and neoplastic tissues routinely-fixed for histological evaluation. EGFR antibody/assay specifically detects the EGFR (HER1) protein in EGFR-expressing cells. This...". As of , FDA records hold no 510(k) clearances under this code and no recalls.

Classification record

Product code
NQF
Device name
Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
FDA definition
The epidermal growth factor receptor (EGFR) antibody/assay is a qualitative immunohistochemical antibody/assay to identify EGFR expression in normal and neoplastic tissues routinely-fixed for histological evaluation. EGFR antibody/assay specifically detects the EGFR (HER1) protein in EGFR-expressing cells. This antibody/assay is indicated as an aid in identifying colorectal cancer patients eligible for treatment with cetuximab, a monoclonal antibody drug. This will be a specialized subcategory for EGFR immunohistochemistry assays under the general heading of the regulation for all Immunohistochemistry assays.
Regulation
21 CFR 864.1860
Device class
Class III
Review panel
Hematology
Submission type
PMA
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
No
Ingested clearances
0
Ingested recalls
0

Companies listing this code with FDA

Companies whose registered establishments list this code

No registered establishment in MDM’s records lists product code NQF.